Arimori K, Nakano M
Department of Pharmacy, Kumamoto University Hospital, Japan.
J Pharm Pharmacol. 1989 Jul;41(7):445-9. doi: 10.1111/j.2042-7158.1989.tb06498.x.
The characteristics of exsorption and/or excretion of disopyramide into the gastrointestinal lumen have been investigated after intravenous administration of the drug at doses of 10 and 30 mg kg-1 to rats by the in-situ single pass perfusion technique. Disopyramide was appreciably excreted into the bile where its levels were approximately ten-fold higher than those in the serum. The exsorption rate of disopyramide and mono-N-dealkyldisopyramide (MND) into the perfusate was increased with an increase in the serum level following an increase from 10 to 30 mg kg-1 in the dose of disopyramide. The average amounts of disopyramide exsorbed into the perfusate were 17.0 and 18.4% at the dose of 10 and 30 mg kg-1, respectively, whereas those of MND were less than 1% at both doses of disopyramide. Oral administration of activated charcoal reduced the serum disopyramide levels after intravenous administration of the drug (20 mg kg-1) compared with the control treatment. By oral administration of activated charcoal, t 1/2 and AUC were decreased to 89 and 82%, respectively, and Cltot was increased to 122% compared with the corresponding control treatment. Vd was not different between the treated rats and control rats. These results suggest that the oral administration of activated charcoal can enhance the clearance of disopyramide and MND from the blood.
采用原位单通道灌注技术,以10和30mg kg-1的剂量给大鼠静脉注射双异丙吡胺后,研究了双异丙吡胺向胃肠道腔的外排和/或排泄特征。双异丙吡胺大量排泄到胆汁中,其水平比血清中约高10倍。随着双异丙吡胺剂量从10mg kg-1增加到30mg kg-1后血清水平的升高,双异丙吡胺和单-N-去烷基双异丙吡胺(MND)向外排液中的外排率增加。双异丙吡胺剂量为10和30mg kg-1时,向外排液中外排的双异丙吡胺平均量分别为17.0%和18.4%,而两种剂量的双异丙吡胺下MND的外排量均小于1%。与对照处理相比,静脉注射双异丙吡胺(20mg kg-1)后口服活性炭可降低血清双异丙吡胺水平。与相应的对照处理相比,口服活性炭后,t1/2和AUC分别降至89%和82%,总清除率(Cltot)增至122%。处理组大鼠与对照组大鼠的分布容积(Vd)无差异。这些结果表明,口服活性炭可增强双异丙吡胺和MND从血液中的清除。